Endothelial nitric oxide gene polymorphism and risk of systemic sclerosis: Predisposition effect of T-786C promoter and protective effect of 27 bp repeats in intron 4

Clinical and Experimental Rheumatology

Volumn 28, Issue 2, 2010, Pages 169-175

  Sinici, Incilay ^a   Kalyoncu, Umut ^a   Karahan, Sevilay ^a   Kiraz, Sedat ^a   Atalar, Enver ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

eNOS gene; Intron 4; Polymorphism; Promoter; Systemic sclerosis

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SYSTEMIC SCLEROSIS; TANDEM REPEAT;

ADULT; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOZYGOTE; HUMANS; INTRONS; LOGISTIC MODELS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK FACTORS; SCLERODERMA, SYSTEMIC; TANDEM REPEAT SEQUENCES; TURKEY;

EID: 77952746903     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. LEROY EC: Systemic sclerosis: a vascular perspective. Rheum Dis Clin North Am 1996; 22: 675-694
2. KAHALEH MB: Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic action. Arthritis Rheum 1991; 34: 978-983
3. MATUCCI-CERINIC M, KAHALEH B: Beauty and the beast. The nitric oxide paradox in systemic sclerosis. Rheumatol (Oxford) 2002; 41: 843-847
4. MONCADA S, HIGGS A: The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012
5. YAMAMOTO T, KATAYAMA I, NISHIOKA K: Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis. J Rheumatol 1998; 25: 314-317 (Pubitemid 28088261)
6. MAZZONE A, CUSA C, BUCCI L et al.: The effects of iloprost infusion on microcirculation is independent of nitric oxide metabolites and endothelin-1 in chronic peripheral ischaemia. Eur J Clin Invest 1999; 29: 1-5.
7. ANDERSEN GN, CAIDAHL K, KAZZAM E et al.: Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis: findings with the soluble adhesion molecules E-selectin, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1. Arthritis Rheum 2000; 43: 1085-1093
8. SUD A, KHULLAR M, WANCHU A, BAMBERY P: Increased nitric oxide production in patients with systemic sclerosis. Nitric Oxide 2000; 4: 615-619 (Pubitemid 32053273)
9. TAKAGI K, KAWAGUCHI Y, HARA M, SUGIURA T, HARIGAI M, KAMATANI N: Serum nitric oxide (NO) levels in systemic sclerosis patients: correlation between NO levels and clinical features. Clin Exp Immunol 2003; 134: 538-544 (Pubitemid 37542097)
10. JANSSENS SP, SHIMOUCHI A, QUERTERMOUS T, BLOCH DB, BLOCH KD: Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 1992; 267: 14519-14522
11. MARSDEN PA, HENG HH, SCHERER SW et al.: Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993; 268: 17478-17488
12. NADAUD S, BONNARDEAUX A, LATHROP M, SOUBRIER F: Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun 1994; 198: 1027-1033 (Pubitemid 24172800)
13. WANG XL, WANG J: Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol Genet Metab 2000; 70: 241-251
14. NAKAYAMA M, YASUE H, YOSHIMURA M et al.: T-786->C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999; 99: 2864-2870 (Pubitemid 29258973)
15. TESAURO M, THOMPSON WC, ROGLIANI P, QI L, CHAUDHARY PP, MOSS J: Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A 2000; 97: 2832-2835
16. JUNGERSTEN L, EDLUND A, PETERSSON AS, WENNMALM A: Plasma nitrate as an index of nitric oxide formation in man: analyses of kinetics and confounding factors. Clin Physiol 1996; 16: 369-379
17. KLEINBONGARD P, DEJAM A, LAUER T et al.: Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol Med 2003; 35: 790-796
18. METZGER IF, SERTORIO JTC and TANUS-SANTOS JE: Relationship between systemic nitric oxide metabolites and cyclic GMP in healthy male volunteers. Acta Physiol 2006; 188: 123-127
19. TANUS-SANTOS JE, DESAI M, DEAK LR et al.:Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol. Pharmacogenetics 2002; 12: 407-413
20. TANGUREK B, OZER N, SAYAR N et al.: The relationship between endothelial nitric oxide synthase gene polymorphism (T-786 C) and coronary artery disease in the Turkish population. Heart and vessels 2006; 21: 285-290 (Pubitemid 44873626)
21. CAM SF, SEKURI C, TENGIZ I et al.: The G894T polymorphism on endothelial nitric oxide synthase gene is associated with premature coronary artery disease in a Turkish population. Thrombosis research 2005; 116: 287-292 (Pubitemid 40994910)
22. AFRASYAP L, OZTURK G: NO level and endothelial NO synthase gene polymorphism (Glu298Asp) in the patients with coronary artery disease from the Turkish population. Acta Biochim Biophys Sin (Shanghai) 2004; 36: 661-666
23. EZZIDI I, MTIRAOUI N, MOHAMED MB, MAHJOUB T, KACEM M, ALMAWI WY: Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy. J Diabetes Complications 2008; 22: 331-338
24. CASAS JP, BAUTISTA LE, HUMPHRIES SE, HINGORANI AD: Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation 2004; 109: 1359-1365
25. KARASNEH JA, HAJEER AH, SILMAN A, WORTHINGTON J, OLLIER WE, GÜL A: Polymorphisms in the endothelial nitric oxide synthase gene are associated with Behçet's disease. Rheumatology (Oxford) 2005; 44: 614-617 (Pubitemid 41487229)
26. OKSEL F, KESER G, OZMEN M et al.: Endothelial nitric oxide synthase gene Glu298Asp polymorphism is associated with Behçet's disease. Clin Exp Rheumatol 2006; 24: S79-82.
27. SALVARANI C, CASALI B, NICOLI D et al.: Endothelial nitric oxide synthase gene polymorphisms in giant cell arteritis. Arthritis Rheum 200; 48: 3219-3223
28. SERRANO NC, PÁEZ C, CORREA PA, ANAYA JM: Endothelial nitric oxide synthase gene polymorphism is associated with systemic lupus erythematosus. J Rheumatol 2004; 31: 2163-2168 (Pubitemid 39453235)
29. KIM JU, CHANG HK, LEE SS et al.: Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease and rheumatic diseases with vasculitis. Ann Rheum Dis 2003; 62: 1083-1087
30. GONZALEZ-GAY MA, LLORCA J, PALOMINO-MORALES R et al.: Influence of nitric oxide synthase gene polymorphisms on the risk of cardiovascular events in rheumatoid arthritis. Clin Exp Rheumatol 2009; 27: 116-119
31. ASSASSI S, MAYES MD, MCNEARNEY T et al.: Polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in systemic sclerosis. Am J Med 2005; 118: 907-911
32. TIKLY M, GULUMIAN M, MARSHALL S: Lack of association of eNOS(G894T) and p22phox NADPH oxidase submit (C242T) polymorphisms with systemic sclerosis in a cohort of French Caucasian patients. Clin Chim Acta 2005; 358: 196-197
33. BIONDI ML, MARASINI B, LEVITI S et al.: Genotyping method for point mutation detection in the endothelial nitric oxide synthase exon 7 using fluorescent probes. Clinical validation in systemic sclerosis patients. Clin Chem Lab Med 2001; 39: 281-282
34. ALLANORE Y, BORDERIE D, LEMARÉCHAL H et al.: Lack of association of eNOS (G894T) and p22phox NADPH oxidase subunit (C242T) polymorphisms with systemic sclerosis in a cohort of French Caucasian patients. Clin Chim Acta 2004; 350: 51-55
35. FATINI C, GENSINI F, STICCHI E et al.: High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis Am J Med 2002; 112: 540-544
36. FATINI C, MANNINI L, STICCHI E et al.: Hemorheologic profile in systemic sclerosis: role of NOS3 -786T > C and 894G >T polymorphisms in modulating both the hemorheologic parameters and the susceptibility to the disease. Arthritis Rheum 2006; 54: 2263-2270
37. HINGORANI AD: Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2000. Atherosclerosis 2001; 154: 521-527
38. WANG MM: Genetics of ischemic stroke: future clinical applications. Semin Neurol 2006; 26: 523-530
39. METZGER IF, SOUZA-COSTA DC, MARRONI AS et al.: Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men. Pharmacogenet Genomics 2005; 15: 565-570
40. METZGER IF, SERTÓRIO JT, TANUS-SANTOS JE: Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes. Free Radic Biol Med 2007; 43: 987-992
41. SANDRIM VC, COELHO EB, NOBRE F, ARADO GM, LANCHOTE VL, TANUS-SANTOS JE: Susceptible and protective eNOS haplotypes in hypertensive black and white subjects. Atherosclerosis 2006; 186: 428-432
42. CATTARUZZA M, GUZIK TJ, SLODOWSKI W et al.: Shear stress insensitivity of endothelial nitric oxide synthase expression as a genetic risk factor for coronary heart disease. Circ Res 2004; 95: 841-847
43. DOSENKO VE, ZAGORIY VY, HAYTOVICH NV, GORDOK OA, MOIBENKO AA: Allelic polymorphism of endothelial NO-synthase gene and its functional manifestations. Acta Biochim Pol 2006; 53: 299-302.